Qi-Tao Yu

机构：Tumor Hospital of Guangxi Medical University

发表论文 3 篇 · 总被引 58 次 · h-index 2

代表论文

• Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial (2024 · Signal Transduction and Targeted Therapy · 被引 36)
• A novel approach to double bond location in long-chain olefinic acids: The mass spectra of 2-alkenylbenzoxazoles (1986 · Journal of Mass Spectrometry · 被引 22)
• Chemical modification in mass spectrometry. 1.: The double bond location of long-chain fatty acids: The mass spectra of 2-alkenyl substituted heterocycles (1988 · Acta Chimica Sinica)